MAP2K3 and non-small cell lung carcinoma: Gu Ling et al. recently revealed that myricetin regulates the p38 MAPK pathway by targeting MAP Kinase Kinase 3 (MKK3) in non-small cell lung cancer cells (NSCLC) [23].